CVS Health Corp.'s 2018 formulary strategy includes shifts in coverage for some prominent diabetes drugs, resumes coverage for a number of drugs previously excluded, and introduces a focus on outcomes-based contracts in oncology, obesity and COPD.
As part of the 2018 strategy, which was publicly announced Aug. 2, the pharmacy benefit manager will exclude...






